Vivos Therapeutics, Inc. Tenant Improvements
Vivos Therapeutics, Inc. (VVOS) had Tenant Improvements of $516.00 thousand as of 2022-03-31, per its 10-Q/A filed 2022-11-25.
Discontinued › Balance Sheet › Assets
us-gaap:TenantImprovements · last filed 2023-03-30
- 2022-03-31: Tenant Improvements $516.00K.
- 2021-12-31: Tenant Improvements $516.00K.
| Period end | Tenant Improvements |
|---|---|
| 2022-03-31 | $516.00K 10-Q/A · filed 2022-11-25 |
| 2021-12-31 | $516.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |